Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 662,171 shares, a decrease of 36.9% from the April 15th total of 1,049,759 shares. Based on an average daily volume of 26,002 shares, the short-interest ratio is presently 25.5 days.
Roche Price Performance
OTCMKTS RHHVF traded up $5.75 on Tuesday, reaching $412.91. The company had a trading volume of 31 shares, compared to its average volume of 20,081. Roche has a 1-year low of $300.15 and a 1-year high of $490.33. The company’s fifty day moving average is $404.13 and its 200-day moving average is $411.44.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
See Also
- Five stocks we like better than Roche
- The $132 Billion Infrastructure Pivot You Might Have Missed
- Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings
- Rewiring AI: NextEra Energy Sparks a Mega Merger
- Flipping the Switch: Is Ford the Next Big Energy Stock?
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
